AllazoHealth, a company that uses artificial intelligence to help pharmaceuticals, payers, and pharmacies improve medication adherence and quality outcomes, announced that pharmacy benefits management executive Greg Watanabe will be joining the company’s Advisory Board. Mr. Watanabe has a distinguished career with over 30 years of leadership in the health care industry, including senior executive experience in strategic planning, operations, project management, sales and business development.
“Greg is an outstanding senior executive who brings deep expertise in pharmacy benefits management that will contribute to our company’s continuing growth trajectory,” said AllazoHealth CEO Clifford Jones. “Not only is he a proven leader, but he is a trained pharmacist with expertise on regulatory changes that impact healthcare, and how the industry might meet those with new technology.”
In his role on the Advisory Board, Mr. Watanabe will provide insights on the impact of innovation on the payer community.
For the nine years prior to joining AllazoHealth, Mr. Watanabe was the President and Chief Operating Officer of MedImpact Healthcare Systems, Inc., one of the nation’s leading PBMs. Previously, he was Vice President Pharmacy Operations with WellPoint Pharmacy Management. In addition, he has worked at numerous healthcare organizations, including VistaCare Hospice Programs, Inc., Argus Health Systems, Inc., and Assisted Care Partners, Inc.
“The healthcare market is changing extremely fast today with new treatment protocols, innovative biopharmaceuticals, new lab tests to measure responses to those pharmaceuticals, and new applications to older therapies,” says Mr. Watanabe. “The challenge has always been the ability to look at data from across the healthcare delivery system in order to help providers make better decisions on how they should focus their limited resources to optimize outcomes. That’s where AllazoHealth’s AI engine excels at the highest levels. I’m excited to be a part of the team.”
Mr. Watanabe has served on the Board of the Pharmaceutical Care Management Association (PCMA), and the National Council for Prescription Drug Programs. As a member of the National Advisory Board for the University of Arizona College of Pharmacy, he provides input to curriculum changes that better prepare graduates for changing needs in pharmacy.
Mr. Watanabe holds a BS Pharm and an MBA, both from the University of Arizona. He resides in southern California. He is joining AllazoHealth’s advisory board effective immediately.
Improving the Effectiveness of Adherence Interventions by
5.45xWe worked alongside Blue Cross Blue Shield of North Carolina and their call center vendor to launch one of our biggest programs, working to improve adherence rates across their population of 104,392 Medicare Advantage Part D (MAPD) patients. We found that AllazoHealth targeted interventions accounted for 5.45 times the uplift in adherence compared to traditionally targeted interventions.